Tesamorelin Safety Profile and Regulatory Status: What the Trials Recorded
A systematic review of what Phase 3 clinical trials actually measured about tesamorelin's safety — organized by organ system, attributed to specific studies, and framed without conjecture. Includes a direct answer to the FDA approval question and a factual account of the GH/IGF-1 and cancer biology question.